Skip to main content

Table 1 Characteristics of female breast cancer patients in the discovery and validation sets

From: Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection

Baseline variable

Discovery set

Validation set

Cases

Controls

Cases

Controls

(n = 20)

(n = 20)

(n = 19)

(n = 41)

Sex (Female)

20

20

19

41

Mean age (years)

59.2 ± 11.4

60.1 ± 7.3

60 ± 15.4

51 ± 6.3

Suspicious mammography with negative cytology

   

4

Smoking status

 Never

12

19

 

19

 Former

3

  

7

 Current

4

1

 

11

 NA

1

  

4

Clinical stage

 0 Tis N0 M0

    

 I T1 N0 M0

10

 

19

 

 IIA T1 N1 M0

5

   

 IIB T2 N1 M0

2

   

 IIIA T0 N2 M0

3

   

ER

 Positive/negative/NA

9/−/11

 

10/4/5

 

PgR

 Positive/negative/NA

8/−/12

 

9/5/5

 

Her2 Neu

 Positive/negative/NA

10/7/3

 

10/4/5

 

Histologic grading

 G1/G2/G3/NA

0/8/5/7

 

2/12/5/0

 

Molecular subtype

 Luminal/Her2-enriched/triple-negative/NA

  

10/3/1/5

 

Comorbidities

 None reported

 

17

 

22

 Diabetes (type I or type II)

   

3

 Allergy

   

1

 Thyroid nodules

   

1

 Hypothyroidism

 

1

 

3

 Chronic gastritis

   

1

 Depressive disorder

   

2

 Hypertension

 

1

 

4

 Hypotension

   

1

 Osteoporosis

   

1

 Hypocholesterolemia

 

1

  

 Epilepsy

 

1

  

 Arthrosis

   

2

 Asthma

   

1